In CKD patients, the efficiency of the antioxidative defense system declines with the progress of the disease and reaches its peak in the end-stage
Every treatment plan starts with labs
Kawano H, Yasue H, Kitagawa A, Hirai N, Yoshida T, Soejima H,
Treatment with immunosuppressants can help manage this condition
Dropping from 1 mg back to 0.5 mg means levels will gradually decline over several weeks rather than immediately dropping
Discussing your medical historyincluding previous medication side effects, migraine history, and baseline blood pressurewith your provider before starting GLP-1 therapy helps contextualize headache risk and enables proactive management